Massachusetts Regulations
Office of Consumer Affairs and Business Regulation/Division of Insurance

Administrative Bulletin 20-08

101 CMR 320.00: Clinical Laboratory Services

Effective for dates of service on or after March 12, 2020

Procedure Code Update

Pursuant to 101 CMR 320.01(3), the Executive Office of Health and Human Services is adding a new procedure code for clinical laboratory services covering diagnostic tests for the 2019 novel Coronavirus (COVID-19). As set forth in 101 CMR 320.01(3)(c), rates for newly added codes are calculated according to the rate methodology used in setting clinical laboratory rates. Added codes without Medicare fees are reimbursed at individual consideration (I.C.). The rate listed in this administrative bulletin is applicable until revised rates are issued by the EOHHS. This administrative bulletin supersedes Administrative Bulletin 20-07 that was previously issued.

The following change is effective for dates of service on or after March 12, 2020.

CODE CHANGE RATE DESCRIPTION
87635 Addition I.C. Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique